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Introduction 
It is well known that mechanical strain acts as a major driver
for tissue adaptations, and the principles of mechanotransduction
and mechano-adaptation have been described in various organ
systems4,8,11. Of note, the mechanical forces vary within the
human body, and musculoskeletal forces are a function of muscle
contractions and mass acceleration, often in relation to gravity. 
Bone particularly is thought to be sensitive to mechanical
strain, and specific yet un-identified force regimens are needed
to maintain bone size and strength8. Several strings of evidence
suggest that larger strains, and also larger strain rates, are more
effective to stimulate bone accrual than smaller strains and
strain rates13,18. Biomechanical analyses suggest that muscle
contractions are the origin of the greatest bone forces even in
the leg12, and it has been suggested that skeletal muscle drives
skeletal development and maintenance15. However, there is cur-
rently no direct evidence to undermine the notion of bone being
a slave of the musculature. Similar arguments may be applied
to other tissues that follow the principle of mechanotransduc-
tion9,19. For example, arteries adapt to blood flow-driven shear
forces that act on the endothelial layer2,10 and mechanical sig-
nals are thought to play a key role in muscle growth4. In all of
these examples, our knowledge of the specific regimens that
drive the adaptive processes in vivo is very limited. This is
mostly because, origin, magnitude and frequency of mechanical
signals are very difficult to assess in the human body, given the
interplay of muscle forces and gravity induced forces as major
sources for mechanical strain in our one ‘G’ environment. 
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Abstract
The present manuscript seeks to discuss methodological aspects regarding the application of the novel unloading orthosis ‘HEP-
HAISTOS’ that has been specifically developed to study physiological effects of muscular unloading without altering the impact
of gravitational loading. The ‘HEPHAISTOS’ has been applied in an ambulatory clinical interventional study. During gait, the
‘HEPHAISTOS’ significantly reduces activation and force production of calf muscles while it completely retains body mass-related
force on the tibia. Eleven healthy male subjects participated in the study and followed their normal everyday lives while wearing
the orthosis. Several measurement sessions have been performed to investigate the time course of structural and functional adap-
tations during intervention and recovery. Follow-up measurements were performed for one year after the intervention. In consid-
eration of the experiences of a unique ambulant unloading study, organizational and methodological recommendations are discussed
in this manuscript. Activity monitoring data obtained with portable accelerometers reveal unchanged gait activities and good subject
compliance throughout the intervention. Moreover, electromyography (EMG) and motion data investigating gait properties on
reambulation day are illustrated. These data show that during the initial steps following removal of ‘HEPHAISTOS’, gait was sig-
nificantly asynchronous indicating an acutely altered motor control in the unloaded lower leg muscles. 
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Models like bed rest14, limb immobilization3 and space
flight21 allow the study of the physiology of gravitational un-
loading. Such studies demonstrate that gravitational unloading
leads to a plethora of de-conditioning processes in various
physiological systems5,7,17. Nonetheless, the above models are
inconsistent with regards to the mechanisms by which forces
with different origins act on the body, as none of these estab-
lished models differentiates between muscle- and gravity-in-
duced forces. Accordingly, the isolated role of gravity-induced
forces as a precursor of physiological adaptations has to date
not been addressed in a clinical study.
The aim of the present project was therefore to specifically
investigate the effects of muscular unloading and thus the ef-
fects of greatly reduced muscular forces, whilst maintaining
normal gravitational loading patterns, upon bone, muscles, ten-
don, blood vessels, cartilage and nervous system in the lower
leg. Bone mineral content (BMC) was selected as primary re-
sponse variable, thus testing the main hypothesis: ‘Body
weight bearing is insufficient to maintain bone mineral content
in the distal human tibia’.
In order to test this hypothesis a novel unloading orthosis (HEP-
HAISTOS, Figure 1, patent application number: 102011082700.5)
has been developed in the German Aerospace Center (DLR) and
at the German Sport University. It has been designed to allow nor-
mal ambulation and thus body weight application to the skeleton
whilst Achilles tendon force is significantly reduced (Ducos et
al., manuscript in revision). Eleven healthy male subjects partic-
ipated in an ambulant study and wore HEPHAISTOS for 56 days
(Figure 1). During this time subjects were completely ambulant
and followed their normal everyday activities. 
The present article presents and discusses data related to de-
sign, subject compliance and adherence of and to the HEP-
HAISTOS study, respectively. It serves the scientific debate
of a novel and unique study design, where a new unloading
device has been applied. In light of the experiences made dur-
ing this study, various aspects concerning subject recruitment,
measurement protocols, subject compliance and application of
the HEPHAISTOS are being discussed. In order to monitor
subjects’ activity profiles and compliance to the studies re-
quirements, portable accelerometers were used and the results
of the activity monitoring are presented in this manuscript. In
addition, gait properties of the first steps following removal of
the orthosis were carefully obtained and the results provide in-
formation on the safety and feasibility of reambulation after
unilateral muscular unloading. We hypothesized that normal
gait activities would be unchanged during the HEPHAISTOS
intervention compared to walking with normal footwear. Fur-
thermore, we expected to observe an asynchronous gait pattern
during the initial steps of re-ambulation following 56 days of
HEPHAISTOS utilization.
Methods
In the following a methodological overview of the study de-
sign is presented. This overview comprises important infor-
mation on how the study was conducted, including details
about sample size calculation, subject recruitment and the ac-
tual intervention. Thereafter, methods and technical informa-
tion of reambulation and activity monitoring measurements
are presented. The results of the latter measurements are pre-
sented in this manuscript.
Study characteristics: The HEPHAISTOS study (HEP-study)
was conducted at the DLR in Cologne, Germany and is regis-
tered at www.clinicaltrials.gov (Identifier: NCT01576081). It
was approved by the Ethics Committee of the Northern Rhine
medical association (Ärztekammer Nordrhein, Düsseldorf, Ger-
many). The time frame for the study was scheduled to 14
months, starting on the 19th of April 2011 with baseline data col-
lection (BDC) and completing with the last measurement of the
recovery phase on the 5th of July 2012. 
Sample size calculation: a sample size calculation has been
performed using BMC data from a previous bed rest study16.
The sample size calculation formula has been chosen assuming
that the mean sampling distribution of the variable of interest
(BMC change) will follow a normal distribution. By estimating
the value of the expected mean paired difference and standard
deviation of BMC inherent to a period of bed rest of 56 days16,
it was possible to calculate the sample size for this study. For
the present ambulant study, we hypothesized that half the loss
of bed rest will be sufficient to verify the main hypothesis. Ac-
cordingly, the threshold was set to a loss of ≥1.7% of tibial
BMC. The formula which allows the calculation of the sample
size for the comparison of paired means was used:
Subjects required = (zα + z2β)
2
 × σ2  
δ
2
Figure 1. The HEPHAISTOS unloading orthosis.
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Where:
zα is the ordinate of the normal distribution for the first order
error probability α
z2β is the ordinate of the normal distribution for the second
order error probability β
σ2 is the standard deviation of the paired difference between
BDC and R+14 values (the within subject anticipated standard
deviation)
δ2 is the anticipated difference between the BMC values of
BDC and R+14.
By accepting a risk of 5% to make an error of the first order
(alpha=0.05) and a risk of 10 % to make an error of the second
order (Beta=0.10; power: 1-beta=0.9), we obtained from the
normal distribution ordinates table:
zα=0.05=1.96
z2β=0.10=1.282
The expected difference between BDC and R+14 BMC val-
ues was set to 1.7%. Thus BMC loss was set to 1.7% (δ2=0.017)
and the intra subject variability was also set to 1.7% (σ2=0.017)
according to data from the literature16.
The equation becomes then:
Subject recruitment: Consequently, 11 male subjects were
recruited for the study. The project was promoted by sending
email information to previous subjects of the DLR database and
to all DLR (Cologne) employees, distributing flyers at public
places, hospitals and universities, broadcasting information in
the local radio (Radio Köln), advertising the project in an online
student job exchange (www.stellenwerk.de) and advertising it
on the DLR-webpage. An initial cohort of 93 interested candi-
dates underwent a strict recruitment process including tele-
phone interviews, subject information presentations, medical
check-ups, psychological questionnaires (FPI: Freiburger per-
sonality inventory), and psychological interviews to eventually
identify the 11 suitable candiates. For inclusion into the study,
subjects had to be psychologically suitable, medically healthy,
aged between 20 and 45 years, in possession of a certificate of
good conduct and body mass indexed between 20 and 30. Ex-
clusion criteria were as follows: smoking, professional athletes,
diabetes, muscle or joint disease, increased risk of thrombosis
(checked via thrombophilia screening), bone fractures 12
months prior to the study, metal implants, any material of os-
teosynthesis, participation in another clinical intervention study
2 months prior to the study, bleeding disorder, anaesthetic in-
tolerance, vascular disease, epilepsy, claustrophobia, herniated
disk, pacemaker, alcohol or drug abuse, anti-inflammatory drug
intake, hyperlipidaemia, kidney disease, hyperhomocys-
teinaemia, vitamin d deficit and chronic back pain. The number
of all excluded candidates is listed in Table 1 for each recruit-
ment stage. 
HEPHAISTOS intervention: A coin was tossed to randomly
assign the intervention leg. The HEPHAISTOS was manufac-
Subjects required =
Subjects required = 10.51
(1.96+1.282)2 × 0.0172  
0.0172
tured from an orthopaedic technics company (ORTEMA GmbH,
Markgrönigen, Germany). The carbon-shaft of HEPHAISTOS
was individually tailored for each subject, taking a plaster cast
of the lower leg as anatomical template. Two weeks before study
start, subjects were familiarized with HEPHAISTOS and final
adjustments were made to facilitate a natural gait pattern. The
following link leads to the webpage of the DLR with a video
clip showing a subject walking with HEPHAISTOS
(http://www.dlr.de/me/en/desktopdefault.aspx/tabid-7389/). The
11 subjects began the intervention in a staggered order, with
three subjects per day over 4 days. Throughout the intervention
subjects had to wear HEPHAISTOS during all locomotive ac-
tivities that required loading of the legs. During this time sub-
jects had to visit the DLR at least once a week for routine
examinations, for measurements or for a weekly report. Table 2
depicts the time course of the entire study for one subject in-
cluding all measurements and events. 
Standardized food protocol: As some of the outcome pa-
rameters of the study are highly influenced by nutrition, a stan-
dardized diet was administered for 4 days on three occasions
before taking blood and urine for the measurement of bone
markers. Energy intake was calculated for each subject using
the subject’s body weight. Energy expenditure was calculated
by summing the basal metabolic rate (BMR) according to the
WHO equation1 plus 40% of BMR for light physical activity,
plus 10% of total energy expenditure (TEE) for energy expen-
diture associated with thermogenesis from food and beverages.
The daily intake of protein (1.2 g/kg BW), fat (<30% of TEE),
carbohydrates (50-55% of TEE), vitamins and minerals
matched the German dietary recommended intakes6. Individ-
ual food packages were prepared and packed by a dietician for
subjects to take home. Moreover, subjects had to fill out a nu-
trition questionnaire on six occasions before giving blood and
24H urine samples.
Blood and urine sampling: Blood and urine samples were
collected under standardized conditions for bone marker as-
sessment. Fasting morning blood was drawn in supine posture
at 7:00 am for each of the sampling days. Once during the
baseline collection period (BDC-7), 4 times during the inter-
vention (HEP2, HEP14, HEP28, HEP56) and four times dur-
ing the recovery period (R+5, R+14, R+28, R+92). Drawn
blood samples were immediately centrifuged, aliquoted and
stored in a freezer at -20 or -80° respectively their requirements
for later analysis. Urine was collected as 24-h urine pools once
Stage Total Excluded Invited Did not 
number attend
Telephone interview 93 15 78 -
Freiburger personality 78 7 24 47
inventory
Medical check-up 24 4 20 -
Psychological interview 20 9 11 -
Table 1. Subject recruitment.
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during baseline collection period (BDC-8), 4 times during the
intervention (HEP1, HEP13, HEP27, HEP55) and four times
during the recovery period (R+4, R+13, R+27, R+90). Each
void was kept dark and cold until final pooling to the 24-h
urine pool. Aliquots were stored at -20 or -80°C respectively
their requirements for later analysis.
Reambulation measurements
On reambulation day gait properties of the six initial steps
without orthosis were investigated using electromyography
(TeleMyo 2400 G2 Telemetry System, Noraxon U.S.A. Inc,
Scottsdale, Arizona, USA) and a motion capture system
(Vicon® Motion Systems Ltd., LA, USA). Both systems were
synchronized using a custom-made trigger. 
Calculation of step length: Reflective markers were placed
on the skin using the standard marker set for the lower body
(plug-in-gait skeleton template, Vicon® Motion Systems Ltd.,
LA, USA). The movement of the marker placed on the
metatarsophalangeal joint of the middle toe was then analysed
off-line and step length was calculated as the tracked distance
between left and right middle toe markers during double limb
support of the stance phase.
Electromyography: Surface electromyography (EMG) was
recorded using a telemetric device. In order to detect side dif-
ferences between intervention and contralateral legs, elec-
trodes were placed on both legs applying the Seniam
recommendations for surface electromyography (www.se-
niam.org) on following muscles: soleus (Sol), gastrocnemius
medialis (GM), tibialis anterior (TA) and vastus lateralis (VL).
Electromyographic recordings were obtained using a sampling
frequency of 1500Hz. Data were off-line rectified and band-
pass filtered (20Hz-500Hz) using MATLAB (Mathworks, Nat-
ick, MA, USA). Thereafter, stance phases were identified
using the middle toe metatarsophalangeal joint reflective
marker and RMS of the filtered signal was calculated for each
stance phase. 
Activity monitoring
Portable accelerometry: In order to quantify possible activ-
ity changes related to wearing HEPHAISTOS, accelerations
(ACCs) of the intervention leg have been continuously
recorded during the entire intervention using portable 3-axis
digital accelerometers (X1-6A, Gulf Coast Data Concepts,
Waveland, USA). Habitual acceleration profiles measured dur-
ing the week from BDC-14 to BDC-7 were taken as reference.
During this period, accelerometers were fixed to the shin using
medical bandages (ORTEMA GmbH, Markgrönigen, Ger-
many). During the HEP intervention they were attached to the
shaft of the orthosis using Velcro® strips. The X-axis of the ac-
celerometer was aligned with the body longitudinal axis, the
Y-axis with the transverse axis and the Z-axis with the sagittal
axis. Accelerometers were synchronized with a computer in-
Table 2. Study overview. Negative numbers refer to study days before intervention start. Days of baseline data collection=BDC; days of HEP-
HAISTOS intervention=HEP; recovery phase=R+.
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ternal clock and set up to automatically start and stop recording
all 3-axis accelerations on a built-in SD card every day, from
5.00 am until 12.00 pm, at a 20 Hz sampling rate. A new data
file was created for every two hours recording. The data were
retrieved on hard disk during the subjects’ weekly visit to the
DLR using the USB connector the accelerometers were
equipped with and the battery of the accelerometer was re-
placed on that occasion. Acceleration analysis was performed
a posteriori using a custom made R program (http://www.r-
project.org). Briefly, data were sorted per study week and
within each weekly data set, files were pooled according to the
time of the day (daytime) they were recorded. Thereafter, a mov-
ing window over 40 samples with 0-overlap was applied along
the pooled data vector obtained for the X-axis, for each daytime
of each week. For each iteration of the moving window, the
standard deviation (SD) of the measured accelerations values
was calculated. Each daytime acceleration data vector could then
be represented by a daytime SD vector. Previously, task related
mean SDs were identified for activities such as sitting (≈0.03
G), standing (≈0.01 G) walking (≈0.3 G), stair ascending (≈0.4
G) and descending (≈0.55 G) (unpublished observations).
Therefore, the weekly proportion of activity during the HEP
study was represented by the counts of SD vector samples
equal or superior to 0.1 G in all daytime SD vectors in relation
Figure 2. Reambulation electromyography. Electromyographic data of the initial six steps after removal of HEPHAISTOS were obtained for
the soleus muscle (Sol), the gastrocnemius medialis muscle (GM), the tibialis anterior muscle (TA) and the vastus lateralis muscle (VL). Root
mean square values were calculated for each stance phase and are expressed for the three initial steps on either side. Soleus muscle RMS
(P=0.044) and TA RMS (P=0.024) were significantly lower on the HEPHAISTOS leg. 
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to the total amount of SD samples. Moreover, the weekly ac-
tivity wasdecomposed intolight (ACTLight with 0.1 G<SD<0.4
G) or heavy (ACTHeavy with SD>0.4 G).
Statistical analyses: All statistical analyses were performed
using using STATISTICA 10.0 for Windows (Statsoft, Tulsa,
Oklahoma, USA, 1984-2008). Electromyography and Vicon®
parameters were analysed applying a repeated measures
ANOVA with leg (HEPHAISTOS vs. contralateral) and step
(step1, step2, step3) as within effect. Accelerometer data were
analysed applying the same test, testing effects for time for
nine study weeks (BDC, W1, W2…W8). Tukey’s test has been
performed for post hoc analyses. All values are presented as
means ± SD and the significance level was set at P≤0.05.
Results and relevant events during the study 
HEPHAISTOS intervention:All eleven subjects completed the
56 intervention days. However, due to reasons which were not
related to the study one subject could not attend the HEP56 meas-
urements. All data of this subject which required pre and post
comparisons, except the bone parameters, were discarded from
further analysis. The EMG reambulation data of one subject had
to be discarded from the analysis due to technical failure.
Reambulation: On the last day of the study, after the last
HEP56 measurement, subjects made their first steps without
HEPHAISTOS. Under controlled conditions subjects were
asked to: (1) move the ankle while sitting, (2) stand on two
feet, (3) sway, shifting body weight from foot to foot, (4) stand
alternately on one foot, (5) sway, from heel stand to tiptoe
stand, (6) if possible tiptoe stand on one leg, (7) squat, (8) jump
carefully on the spot, (9) walk with assistance, (10) walk alone.
Ground reaction forces and centre of gravity motions of move-
ments 1-8 were measured using a force plate (Leonardo
Mechanograph®, Novotec, Pforzheim, Germany). During the
whole procedure EMG was recorded from soleus, gastrocne-
mius medialis, vastus lateralis and from tibialis anterior mus-
cles using a telemetric EMG device. In addition gait properties
were recorded using the Vicon® motion capturing system. The
results of the gait trials (10) are presented below. On reambu-
lation day a professional physiotherapist treated each subject
for 60 minutes and checked the mobility of the unloaded ankle,
which was for no subject considered as a serious counter indi-
cation for reambulation. Five days after reambulation one sub-
ject complained about pressure pain in the area of the
intervention forefoot and at the dorsum of this foot. Morton’s
neuroma was diagnosed which was treated conservatively, and
it was judged that this was likely to be facilitated by the subject
having splay feet. The ailment vanished 12 weeks after ream-
bulation. All ankle plantarflexor torque tests after HEP56 were
cancelled for that subject. 
Reambulation electromyography: During the initial six steps
without orthosis, RMS of the soleus muscle was by 42.7%
(SD=38.3%) significantly (leg: P=0.044) smaller in the HEP-
HAISTOS leg if compared to the contralateral leg. There was
no difference of soleus muscle EMG between steps for either
side (step: P=0.59). The RMS of the tibialis anterior muscle
was also significantly (leg: P=0.024) reduced by 39.2%
(SD=43.9%) in the HEPHAISTOS leg, with no differences be-
tween steps for either side (step: P=0.7). There were no leg or
step specific differences between gastrocnemius medialis mus-
cle (leg: P=0.38; step: P=0.87) and vastus lateralis muscle (leg:
P=0.25; step: P=0.13) RMS (Figure 2).
Reambulation step length: The step length of the contralat-
eral leg was by 16% (SD=16%) significantly (leg: P=0.012)
shorter compared to the step length of the HEPHAISTOS leg.
There was no length difference between steps (step: P=0.21)
(Figure 3).
Accelerometer activity monitoring: The percentage value of
the accelerometer recordings that have been assigned to activ-
ity (ACTTotal) has decreased significantly over time (P=0.023).
Post hoc testing revealed a significant decrease of ACTTotal
from 9.7% (SD=4.5%) at BDC to correspondingly 6.7%
(SD=3%; P=0.04), 6.7% (SD=2.5%; P=0.04) and 6.4%
(SD=2%; P=0.02) for intervention weeks five, six and seven.
The percentage value of recordings that have been assigned to
ACTHeavy has also decreased over time (P<0.001). Post hoc
testing revealed a significant decrease of ACTHeavy (P<0.001)
from 2.7% (SD=1.5%) at BDC to values below or equal to 1%
for all intervention weeks (Figure 4). The percentage value of
the recordings that have been assigned to light activities re-
mained unaffected throughout the study (P=0.5).
CT-measurements: All CT-measurements were approved by
the Federal Office for Radiation Protection, Berlin, Germany.
Two x-ray devices were being applied in the present study. A
Figure 3. Reambulation step length. Step length was assessed using
the Vicon® motion capturing system. One step was determined as the
distance between left and right middle toe markers during double limb
support of the stance phase. For the initial six steps after removal of
HEPHAISTOS, steps were significantly (P=0.012) shorter on the
contralateral side.
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high resolution Xtreme CT- scanner (Scanco, SCANCO Med-
ical AG, Brüttisellen, Switzerland) for measurements at BDC-
3 and R+25 and a peripheral quantitative tomographic scanner
(XTC 3000, Stratec Medizintechnik), for all other bone density
measurements. The Xtreme CT scan was conducted in the Uni-
versity clinic in Erlangen, Germany, which 3 subjects could
not attend. The overall mean radiation dose for each subject
and all measurements was 0,035356 mSv. 
MRI-measurements: The cartilage measurements required ad-
ministration of the contrast agent Gadopentetic acid (Magnevist®).
Two subjects showed symptoms of intolerance and were excluded
from this measurement. One subject refused the procedure.
Standardized nutrition, blood and urine sampling:
All samples could be collected as planned. The results of
those measurements will be published together with the data
for the long term bone adaptation (Ducos et al, in preparation). 
Discussion
Scientific relevance: The significant reduction of mechani-
cal stimuli as a consequence of gravitational unloading under
conditions like bed rest, SCI or space flight is considered as a
major source for bone loss20. For all of these conditions mus-
cular unloading is combined with a change of gravity effects.
Exercise interventions as applied for instance in bed rest, that
try to compensate for the extensive reduction of muscle work,
have only been partially efficient to counteract bone loss17.
However, these interventions do not consider a potential role
of gravitational acceleration. The investigation of the effects
of the earth attraction force independently from the effects of
muscle contraction forces is a logical complement to previous
studies and the results of such a novel study approach greatly
add to the current knowledge of bone adaptation (Ducos et al.,
in preparation). Moreover, the application of HEPHAISTOS
offers a novel and unique possibility to study the specific ef-
fects of gravitational accelerations upon functional and struc-
tural adaptations of the other investigated organs22. 
HEPHAISTOS intervention: The intervention with the novel
unloading device was very satisfactory. All eleven subjects
completed the 56 intervention days without serious complica-
tions. Occasionally occurring pressure spots could be success-
fully counteracted using cushioning and re-adjusting the elastic
foot of HEPHAISTOS (see Figure 1). The weak point of the
HEPHAISTOS was the anti-slippery sole glued under the car-
bon prosthetic foot, which showed signs of premature wear
during the second week of the intervention. However, selection
of a superior material allowed the second sole to outlast the
resting intervention time. Our experiences with the novel de-
vice made us confident enough to further pursue its application
in upcoming clinical trials.
Ambulant study design and subject compliance: The major
challenge of an ambulant study design is that subjects cannot
be monitored for the biggest part of the intervention. To wear
the HEPHAISTOS for 56 days during all daily activities re-
quired a great amount of motivation and mental strength from
Figure 4. Activity monitoring. Subjects‘ activities were monitored
throughout the entire study (BDC=baseline data collection; W1,
W2…W8= intervention weeks) using portable accelerometers that
were fixed to the lower leg. Panel (a) depicts the percentage value of
all acceleration recordings that were assigned to general activity
(ACTTotal). Panel (b) shows the percentage value of the recordings that
were assigned to ‘light’ activities (ACTLight, e.g. gait) and panel (c)
depicts the percentage value of the recordings that were assigned to
‘heavy’ activities (ACTHeavy, e.g. jumping, running). #P=0.04,
+P=0.02, *P<0.001. 
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the subjects. Several compliance strategies were developed to
ensure that all subjects would use the HEPHAISTOS as stipu-
lated and that all subjects would complete the 56 days: (a) Psy-
chological questionnaires (FPIs) and the psychological
interviews were applied to optimize our subject selection. The
psychological assessment helped us to find reliable subjects
who had a real interest in the topic and perceived the participa-
tion in our study as an interesting experience. The above com-
bination of psychological subject characteristics was in our
opinion crucial for a successful study. (b) The application of
accelerometers to monitor subject activity throughout the entire
study provided a certain control tool. The data obtained through
accelerometry reveal that subjects wore the HEPHAISTOS or-
thosis throughout the entire study as the fraction of ‘light’ ac-
tivities e.g. gait was comparable between BDC and all other
intervention weeks. The finding that heavy activities were sig-
nificantly reduced during the intervention can be basically at-
tributed to the function of the HEPHAISTOS. Locomotive
activities like jumping or running, leading to high acceleration
profiles, are restricted with this device. (c) Social events before,
during and after the study created a positive team spirit and a
familiar atmosphere between subjects and investigators. They
also helped to sustain a working relationship between subjects
and investigators. (d) One of the project scientists participated
as subject in the study. Thus, potential concerns regarding the
intervention and measurement procedures have certainly been
diminished. As an indication of good subject compliance the
distinct artery adaptations shall be mentioned here, which could
be detected for all of the eleven participants22. 
Reambulation 
The gait trials on reambulation day clearly indicate that
motor control of the HEPHAISTOS leg was acutely impaired
for the initial steps without orthosis. When wearing HEPHAIS-
TOS, the soleus muscle is primarily impacted (Ducos et al.,
manuscript in revision) and it therefore appears logical that
muscle activation of this muscle is acutely impaired after 56
days HEPHAISTOS intervention. During the initial trials with
HEPHAISTOS it seemed that muscle activation of the TA was
less affected, however, reambulation data suggest that over the
8 intervention weeks, subjects learned to deactivate the dorsi
flexor muscle as TA RMS on the HEPHAISTOS side was sig-
nificantly decreased during the initial steps. Gastrocnemius me-
dialis and vastus lateralis muscle activity seemed to be less
impacted after the intervention, however, this is not unexpected
as the HEPHAISTOS orthosis was developed to primarily re-
duce soleus plantar flexor torque production during gait. The
apparent acute imbalance of muscle activation resulted then in
an asynchronous gait pattern and it happened that step length
of the control leg was significantly reduced. This altered gait
pattern can most likely be attributed to a reduced stance time
of the HEPHAISTOS leg. Nonetheless, gait properties normal-
ized quickly and except for the subject suffering from Morton’s
neuroma, all subjects showed normal gait properties within a
few days after reambulation. 
Conclusion
In summary, one can conclude that the HEP-project was
very successful. The present study adds important knowledge
to our current understanding of physiological adaptations in-
duced by muscle unloading. Although the asynchronous gait
properties on the first day after removal of the orthosis, the ap-
plication of HEPHAISTOS had no major side effects and all
subjects recovered completely within the time frame of the
study. Morton’s neuroma, probably as a result of splay foot
may be a complication during recovery from wearing the HEP-
HAISTOS orthosis, and it might also be expected after immo-
bilisation with other models. Although there is no direct proof,
activity monitoring data and several other strands of indirect
evidence suggests that subjects’ compliance with the protocol
was very good, thus underlining the feasibility of ambulant
immobilisation studies.
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